DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Gluz O, Nitz U, Liedtke C. et al.
Comparison of neoadjuvant Nab-Paclitaxel+Carboplatin vs.
Nab-Paclitaxel+Gemcitabine in triple-negative breast cancer: Randomized
WSGADAPT-TN Trial Results.
J Natl Cancer Inst 2018;
110: 628-637
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.